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ABSTRACT: Self-propelled motors have been developed with
promising potential for medical applications. However, most of
them have a size range at the microscale, which limits their further
research for in vivo experiments. Previously, our group developed
nanoscaled motors with a size of around 400 nm with several
merits, for example, delivering both hydrophobic and hydrophilic
drugs/proteins, using biocompatible fuels while being able to
control their motion, and showing adaptive changes of their speed
and navigation to changes in the environment. It is also well-
known that nanoparticles that are around 20−200 nm in size have
advantages in overcoming cellular barriers and being internalized
into cells. Therefore, lowering the size range of this stomatocyte
nanomotor is crucial. However, the strict control of the size of
vesicles in such a low regime as well as their shape transformation into folded stomatocyte structures is not trivial. In this
study, we fabricated ultrasmall stomatocyte polymersomes with the size of around 150 nm, which could be a promising
carrier for biomedical purposes. We demonstrated that the addition of PEG additive allows for both shape transformation
of small polymersomes into stomatocytes and encapsulation of biologics. Biocatalyst catalase was encapsulated in the
inner compartment of the nanomotor, protecting the enzyme while providing enough thrust to propel the motors. The
ultrasmall stomatocyte motor system allowed propelled motion by converting H2O2 into O2 in the presence of only 2 mM
H2O2, and the velocity of motors correlated to the O2 production. Compared to small stomatocyte nanomotors, ultrasmall
stomatocyte motors demonstrate enhanced penetration across the vasculature model and increased uptake by HeLa cells
in the presence of fuel.
KEYWORDS: polymersomes, nanomotors, biocatalyst, cell uptake, oxygen production, biomedical applications
Inspired by natural molecular motors,
1−3 scientists have
been focusing on developing motors from the macro- and
micro- to the nanometer scale for numerous potential
applications such as nanoscale fabrication, environmental
remediation, and biomedicine.4−10 Recent advances in
micro/nanomotor research have made them promising tools
for addressing many biomedical challenges owing to their
unique features, including fast motion, high cargo loading and
towing force, and ease of surface functionalization.11−13 For
example, several motors have already demonstrated great
potential for targeted drug delivery and cargo release eﬃciency,
including self-propelling polymer multilayer nanorockets and
TAT peptide-modiﬁed stomatocyte nanomotors.14,15 How-
ever, there are still many bottlenecks that need to be addressed,
such as use of metal surfaces that are toxic to humans and the
current size spectra that are not suitable for clinical trials. The
size of nanoparticles is one of the most important factors
determining whether the particles can pass certain biological
barriers or not (e.g., blood, extracellular matrix, and cellular
barriers).16−19 For instance, particles above the size range of
4−5 nm could avoid renal and hepatic clearance and have a
longer blood circulation time. Meanwhile, if their sizes are
smaller than 200 nm, nanoparticles are more prone to
extravasate from tumor vasculature as vascular abnormalities
in tumor tissues lead to permeability of the vascular
system,20,21 allowing tumors to accumulate small particles
based on the physiological principle.22 In this context,
researchers have shown that smaller nanomotors present an
advantage in overcoming cellular barriers and improving
cellular uptake.23 For instance, researchers have developed
Janus mesoporous silica nanomotors (MSNs) of less than 100
nm as carriers for drug delivery with controlled release.24
However, clearance of these nanomotors by the mononuclear
phagocytic system (MPS) at the blood barrier is possible, due
to the lack of biocompatible elements such as poly(ethylene
glycol) (PEG).25 PEGylation onto the surface of nanoparticles
prevents interaction between nanoparticles and with biological
ﬂuid components, such as plasma proteins, leading to reduced
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MPS clearance and longer circulation time.16 Hence,
developing delivery vehicles smaller than 200 nm with the
capability of longer circulation time and tumor vasculature
penetration is still challenging.
Our group has previously used a “bottom-up approach” to
fabricate nanomotors by changing the shape of supramolecular
assembled polymersomes into bowl-shaped stomatocytes.26
These stomatocyte nanomotors have been fabricated to have
unique properties such as controlled drug release,27 controlled
speed,28 and protein encapsulation.29 Although the size of our
stomatocyte motors is at the nanoscale, they are still larger
than 200 nm, which is not ideal for systemic delivery and
biomedical applications. Moreover, the method we developed
for protein encapsulation is laborious, time-consuming, and
not achievable with smaller-sized particles.
In this paper, we have designed ultrasmall stomatocyte
nanomotors (USSNs) of around 150 nm by using the
extrusion method. In our previous work, several methodologies
designed to achieve the structural transformation of polymer-
somes into stomatocytes have been developed, such as direct
dialysis,30 reverse dialysis, and organic solvent addition.26,29
However, none of these methods were suitable to transform
smaller-sized polymersomes into stomatocytes.27,31−35 This
may be due to the osmotic pressure created by these methods,
which is not high enough to cause the shape transformation of
smaller polymersomes. Recently, a new methodology for
tuning the shape of polymersomes has been described, which
involves adding PEG to the ﬂexible polymersomes, where PEG
is considered to create a higher osmotic shock for shape
transformation.36 Here, PEG solution was added to the
Figure 1. Scheme for the preparation of size-controlled poly(ethylene glycol)-b-polystyrene (PEG−PS) stomatocyte-like particles and
enzyme-loaded nanomotors.
Figure 2. TEM (a,b) and cryo-TEM images (a1,b1) of polymersomes before and after extrusion. TEM (c) and cryo-TEM images (c1) of size-
controlled stomatocytes. (d) Size distribution of polymersomes before extrusion and ultrasmall stomatocytes. Scale bar: (a−c) 500 nm; (a1−
c1) 100 nm.
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extruded solution in the presence of enzymes (to power
motion via chemical gradients) to form uniform USSNs. By
using this method, we can encapsulate proteins and thus
protect them from denaturation. These size-controlled
stomatocytes are also reversible, meaning that they can be
converted back to polymersomes by adding organic solvent
(Figure 1). Moreover, the USSN studied in this way was more
eﬃcient at extravasating the tumor vasculature system and
accumulating into tumor cells in comparison to previously
reported stomatocyte nanomotors.
RESULTS AND DISCUSSION
Self-Assembly of Stomatocytes with Controlled Size.
Polymersomes were fabricated by self-assembly of diblock
copolymers with an average size of 371.1 nm (Figure 2d). The
polymersomes thus formed were extruded with a ﬁlter
membrane with a pore size of 220 nm to form ultrasmall
polymersomes of around 150.3 nm (Figure 2d). The size and
morphology of both polymersomes were studied using
dynamic light scattering (DLS), transmission electron
microscopy (TEM), and cryo-TEM (Figure 2a,b,d). After
uniform ultrasmall polymersomes were formed, PEG solution
was added to provide an instantaneous osmotic shock for the
shape transformation from polymersomes to stomatocytes.36
Compared to our previously synthesized stomatocytes, more
PEG was required for shape transformation of ultrasmall
polymersomes as smaller vesicles with higher curvature stress
need more osmotic pressure for membrane folding.37 The
synthesized ultrasmall stomatocytes were around 153.6 nm and
were very uniform with a small opening as observed by DLS,
TEM, and cryo-TEM (Figure 2c,d). As has previously been
shown, osmotic pressure induced by the presence of additives
in the solution causes shape transformation because the inside
volume of polymersomes will decrease according to the
diﬀerent osmotic pressure created by diﬀerent amounts of
molecules introduced.37−39 In our study, the PEG solution
circumvents the limitation in the osmotic shock of other
methods such as dialysis and the addition of organic solvents
and induced the shape changing of small polymersomes, thus
allowing the fabrication of ultrasmall stomatocyte nanomotors.
Eﬀects of Amphiphile Molecular Weight and Bilayer
Thickness on Stomatocyte Formation. Additive PEG
addition methodology is suitable for fabricating stomatocyte
polymersomes even in the ultrasmall size scale; however,
whether this system is robust and can be systematically used
for polymersomes within diﬀerent parameters is still not clear.
For example, molecular weight is an important factor for
forming polymersomes and might inﬂuence the bilayer’s
thickness. In order to investigate this eﬀect and test the
suitability of the technique to a wider range of amphiphiles, we
performed the shape transformation using the PEG addition
method on polymersomes assembled from amphiphiles with
diﬀerent units of PSn. Brieﬂy, PEG44-b-PSn block copolymers
were assembled as described previously into polymersomes,
which were further extruded to produce small polymersomes
with diﬀerent membrane thicknesses. With the addition of
PEG solution, polymersomes reshaped into stomatocytes. As
shown in Figure 3, for polymersomes formed from amphiphiles
with 170 units of PS, 5 μL of PEG solution led to a mixture of
prolates, tubes, and stomatocytes with a large opening, whereas
with 10 μL of PEG solution, a small opening of stomatocytes
was found, and the ratio of small opening stomatocytes
increases to 100% when 20 μL of PEG solution was added
(Figure 3a−c). For the 200 and 230 units of PS polymersomes,
the shape transformation trends are similar to those of 170
units of polymersomes, and it is worth noting that the amount
of PEG solution was also increased within the increasing of PS
units. Therefore, 30 and 40 μL of PEG solution was required
to fabricate pure small opening stomatocytes instead of 20 μL
of PEG solution (Figure 3d−i). Theoretically, molecular
weight of amphiphiles aﬀects the thickness of bilayers as d ∼
(Mw)
0.5 (d is the core thickness), and it is also supported by
cryo-TEM measurements.40 This has been indeed conﬁrmed
by electron microscopy measurements, as shown in Figure S1;
a membrane thickness of 170, 200, and 230 units of PS
stomatocyte polymersomes was measured and found to be
around 15, 17.5, and 20 nm, respectively. The diﬀerence in
membrane thickness causes the diﬀerences in curvature stress
and the bending energy required for shape transformation.39
The PEG addition method is therefore promising for shape
transformation of diﬀerent polymers, and the introduced
osmotic pressure is enough for bending the bilayers, even
though PS units were increased to 230, as long as the amount
of PEG was also optimized.
Encapsulation of Catalase. Enzyme-powered motors
have been widely studied as promising new generation motors
as enzymes are considered to be versatile and biocompatible
alternative catalysts and also show higher eﬃciency for
propelling motors, which makes enzyme-powered motors
ideal tools for medical research.41,42 Several enzymes have
been used as biocatalysts, such as urease, catalase, glucose
oxidase, alkaline phosphatase, etc.,41,43 which inspired us to
fabricate ultrasmall nanomotors with a biocatalyst system. To
fabricate USSN, catalase was encapsulated in the inner
compartments of stomatocytes. This was carried out by adding
catalase to the extruded polymersomes followed by the PEG
addition to the solution. During the shape transformation of
polymersomes, catalase is encapsulated in the stomach of the
Figure 3. TEM for shape transformation of small polymersomes
into small stomatocytes, with diﬀerent PS lengths and diﬀerent
amounts of PEG2000. (a−c) PS length of 170, with the addition of
5, 10, and 20 μL of 100 mg/mL PEG solution; (d−f) PS length of
200, with the addition of 10, 20, and 30 μL of 100 mg/mL PEG
solution; (g−i) PS length of 230, with the addition of 20, 30, and
40 μL of 100 mg/mL PEG solution. Scale bars: 200 nm.
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stomatocytes, which allows the assembly of the nanomotor
propelling the structures in the presence of H2O2. TEM and
cryo-TEM were used to visualize the morphology of these
samples (Figure 4b−b1). More PEG was required (50 μL) to
achieve the shape transformation of polymersomes in the
presence of catalase in comparison to the transformation
without catalase in the reaction mixture. The increase of PEG
required for the shape transformation might be due to the
interaction between enzymes and the membrane of polymer-
somes; however, no signiﬁcant change in the ﬁnal morphology
of stomatocytes was observed.
Releasing of the encapsulated cargoes from the stomach of
stomatocytes is also important for further studies, which will
give us more information on the encapsulation eﬃciency of
biologics, etc. Whether rigid stomatocytes can turn back to
polymersomes or not therefore becomes pivotal. As shown in
Figure S2, when the starting point of the shape transformation
changed to rigid stomatocytes with enzymes encapsulated, the
reversibility of USSN was observed by slowly adding organic
solvent. From TEM and cryo-TEM images, the reverse shape
transformation was initiated with 150 μL of organic solvent to
stomatocyte solution and is completed when the organic
solvent addition reaches 450 μL, after which most of the
stomatocytes change back to polymersomes. After releasing
catalase from the stomach, the encapsulation eﬃciency was
quantiﬁed by SDS-PAGE. Figure 4c showed the standard curve
of catalase, which was used to quantify the amount of catalase
released from stomatocytes. The correlation curves and the
quantiﬁed bands are shown in Figure S3. Amplex red assay was
employed to study the activity of the encapsulated catalase, and
the calibration curve for enzyme activity is shown in Figure
S3c. Based on these curves, 16.53 μg of catalase was
Figure 4. (a) Scheme for the study of encapsulation eﬃciency. TEM (b) and cryo-TEM images (b1) of size-controlled stomatocytes
encapsulated with enzymes. (c) SDS-PAGE of released enzymes from the stomatocytes and from a catalase standard curve solution. Scale
bar: (b) 500 nm; (b1) 100 nm.
Figure 5. Movement analysis of catalase-driven ultrasmall stomatocyte nanomotors at diﬀerent concentrations (2−20 mM H2O2). (a)
Velocity of catalase-encapsulated ultrasmall stomatocyte nanomotors at diﬀerent fuel concentrations; the velocity was extracted from the
ﬁtting of the average MSD of catalase-encapsulated ultrasmall stomatocyte, calculated from the tracking coordinates of, on average, 50
particles. (b) Typical tracking paths of nanomotors, recorded for 2 s. (c) Oxygen production of catalase-encapsulated ultrasmall stomatocyte
nanomotors. (d) Relation between velocity and oxygen production.
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determined to be encapsulated via SDS-PAGE, which is
diﬀerent from the result from the activity assay (12.47 μg); the
discrepancy is most probably due to the denaturation of
proteins during the loading procedure. After the encapsulation,
enzyme activity decreased by 24.57%. Compared to previous
research with nanoporous silica spheres that retained 62%
activity of the encapsulated enzyme,44 this method kept
enzymes more active. In our previous described methods for
enzyme encapsulation, enzymes were exposed to plasticizers
for 30 min,29 which might aﬀect even further their activity. By
using this method for encapsulating proteins, they would just
be exposed to organic solvent for several seconds, which
protects the enzyme from denaturation. Moreover, the
existence of PEG solution plays the role of additive in the
stabilization of proteins.45,46 Thus, by selecting the appropriate
encapsulation method, we were able to stabilize the enzyme
and preserve its activity quite well for further analysis of
movement for biomedical applications. In terms of protein
encapsulation, this method can also be applied systematically.
With the polymeric coatings, proteins can be protected from
immunogenicity, which is promising for protein therapeu-
tics.47,48
Motion Characterization of Ultrasmall Stomatocyte
Nanomotors. To study the autonomous movement of
enzyme-powered USSNs, nanoparticle tracking analysis was
carried out to record and analyze the real-time movement of
particles.26 USSNs without fuel (controls) displayed Brownian
motion, which was conﬁrmed by the linear ﬁtting of the MSD
curve (⟨r2⟩ = 4Dt).29,49 Adding diﬀerent concentrations of
H2O2 to the catalase-encapsulated USSN solution resulted in a
parabolic ﬁtting of MSD curves (Figure 5a). The velocity of
USSN increased from 13.69 ± 1.11 to 20.52 ± 0.35 μm/s with
an increase in concentration of H2O2 from 2 to 20 mM. The
USSN measured speeds of 117 body lengths/s in the presence
of 10 mM H2O2, which is quite fast when compared to other
motors of similar size.50 Additionally, these motors have a
smaller size that could explain the higher speeds as less energy
is required to power smaller particles.29 Research from other
groups also tried to lower the concentration of H2O2, for
example, 0.5% H2O2
51 and 1.5 wt %52 were used for powering
motors, which are still higher than 20 mM (0.06%). The sizes
of these motors are still at the microscale, which made them
more diﬃcult to be propelled. However, with similar-sized
Janus particles, speeds lower than those with our stomatocyte
nanomotors were recorded, which could be attributed to the
catalyst choice; in this case, Pt nanoparticles were used for the
Janus system which has catalytic eﬃciency lower than that of
catalase, showcasing the importance of catalyst choice used to
power the motion as well as the shape of the nanomotors.50,53
Sample trajectories for the movement of nanomotors at
diﬀerent H2O2 concentration is shown in Figure 5b. At 0 mM,
only Brownian motion was observed with no net displacement
of the particles. However, an increase in net displacement was
observed with an increase in concentration of fuel. The
mechanism of motion for bubble-propelled motors has been
extensively studied; basically the velocity of motors is mainly
dependent on the consumption of H2O2 and the O2
production and the formation of bubbles.54−56 However,
most of these studies were based on tubular motors and also
on a microscale, which may not provide direct evidence for
further understanding of nanoscale bubble-propelled motors.
On the other hand, tracking nanoscale motors is still a
challenge as they are too small to be observed using optical
microscopy techniques, let alone see the bubble production. By
using an oxygraph system, the oxygen produced by
decomposing H2O2 can be detected, which may give us
some information on the relationship between bubble
production and the movement of nanomotors. Here, to
demonstrate that the movement of USSNs is related to the
decomposition of H2O2, the O2 evolution rate was studied for
diﬀerent H2O2 concentrations (Figure 5c). As expected,
increased oxygen evolution was observed with an increase in
H2O2 concentration, and this directly correlated with the
increase in the speed of the nanomotors (Figure 5d), which
suggested that bubble production might be the essential factor
in powering motors.
Enhanced Penetration Across Vasculature Models
and Internalization of Nanomotors with Controlled
Size. To accumulate nanoparticles into tumor tissues, a passive
delivery pathway based on the enhanced permeation and
retention (EPR) eﬀect has been actively used, due to the
presence of immature and permeable tumor vasculature.57−59
However, this passive method can also be limited by the pore
size of these leaky vessels. Furthermore, most of the tumors
have a vascular pore size ranging from 100 to 800 nm,21,60,61
and nanoparticles with a size of around 130 nm produced
promising results from the perspective of the EPR eﬀect.62 In
this study, the penetration of nanomotors through a conﬂuent
monolayer of pulmonary artery endothelial cells was studied to
investigate the size inﬂuence of nanomotors when passing
through the vasculature model. Corning transwell inserts with
porous membranes (pore size 3 μm) were used to seed cells,
and small stomatocyte nanomotors (SSNs) and USSNs made
by a PEG addition method (Figure S4) were added on the top
compartments of the insets, as shown in Figure S5a.
Nanomotors in the top and bottom compartments were
collected and washed by centrifugation after 2 h incubation.
Fluorescence intensity was studied using a plate reader. As
shown in Figure S5b, in comparison with SSN particles, USSN
particles’ translocation increased by 13.64%, from 38.59 to
52.23% in the absence of H2O2. When 2 mM H2O2 was added
as a fuel for the motion of nanomotors, 65.93% of USSN
particles were present in the bottom chamber, compared to
SSN particles (48.91%). A 17% increase was observed,
showing that USSN is much better for undergoing tumor
vasculature both with and without fuel. To demonstrate the
formation of EPR model, transepithelial/transendothelial
electrical resistance (TEER) was measured via a chopstick
electrode EVOM2 (World Precision Instruments). The TEER
was also measured after conducting the experiment, to study
whether the cell monolayer permeability was changed by the
motors and the addition of H2O2. The morphology of the
monolayer endothelial cells was also studied by confocal laser
scanning microscopy (CLSM) before and after the experiment.
As shown in Figure S6, the cell monolayer was formed, and no
diﬀerence was found from the TEER and cell morphology
studies before and after the experiment was conducted, as
incubation time is limited.
It is also well-known that cellular uptake of nanoparticles
(for example, liposomes,63 gold particles,64 and silica
particles65) is size-dependent and plays a major role in the
uptake eﬃciency and endocytic pathway, although physico-
chemical properties such as surface charge and surface
functionality could also aﬀect the internalization of NPs.17
When it comes to motors, similar rules are expected to apply,
although the scenario is more complex because factors like
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interactions between active motors and dynamic surfaces (such
as cell membranes), fuels that are used to power the motors
and mechanism of motion, can aﬀect particle uptake. In this
experiment, we compared two nanomotors with diﬀerent size
distributions fabricated by the same polymer to investigate the
inﬂuence of size on cellular uptake using human cervical cancer
cells (HeLa cells) as a model cell. The material toxicity was
studied by detecting the cell viability after the nanomotors
Figure 6. HeLa cells incubated with nanomotors and ultrasmall nanomotors in the presence of 2 mM H2O2 and without hydrogen peroxide
for 3.5 h. Cell nuclei were dyed with DAPI after cells were ﬁxed; Nile Red was encapsulated in the nanomotors for ﬂuorescence. Scale bar:
10 μm.
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were incubated with HeLa cells for 24 h. As shown in Figure
S8, no signiﬁcant cytotoxicity was observed after the cells were
incubated with ultrasmall stomatocyte polymersomes and
ultrasmall stomatocyte nanomotors. Similar results were also
observed when cells were incubated for a short time scale (3.5
h) and studied by CLSM, as shown in Figure S9, in which the
cell viability was detected by propidium iodide. A Leica
Microsystems TSC SP8 HyVolution confocal microscope was
used to visualize the cellular uptake after HeLa cells were
incubated with SSN and USSN for 3.5 h,66 and the
ﬂuorescence area from Nile Red was quantiﬁed with Fiji. As
shown in Figure 6, the USSN showed a cellular uptake
eﬃciency higher than that of the SSN, with 3.7 times higher
ﬂuorescence area observed. Although in the presence of 2 mM
H2O2, USSN showed higher uptake eﬃciency and the
ﬂuorescence area from Nile Red was 2.2 times more than
that of the SSN. Compared to the samples without H2O2, there
was increased internalization with both nanomotors, which is
mostly due to the active movement of motors as no cell death
was observed during the experiment. 3D videos of these cells
were made to prove that nanomotors were actually embedded
inside the cells instead of attaching to the membrane (Video
S1 and Video S2). Moreover, ﬂow cytometry was also recruited
for further uptake quantiﬁcation. As shown in Figure S11,
USSNs showed the highest uptake eﬃciency with the presence
of fuel, following the trend observed by CLSM. To study
whether H2O2 damaged the cell membrane during the
experiment, which might lead to a higher uptake but not the
motion of nanomotors, a cell membrane permeability assay
was conducted using propidium iodide because it is not
membrane-permeable. As shown in Figure S10, H2O2 had
almost no inﬂuence on the cells when nanomotors were added
to incubate with the cells. In contrast, when polymersomes
were added together with H2O2, the cell membrane was more
permeable. The diﬀerence between samples was the presence
of catalase that decomposes H2O2 to O2, which decreases the
H2O2-related damage. As the H2O2 concentration decreases,
moreover, catalase has also been used as an antioxidant enzyme
to detoxify H2O2,
67 which protects cells from being damaged.
The above results suggest that smaller-sized nanomotors are
more promising for biomedical applications, as they exhibit
positive results in passing through the leaking vessels and cell
membranes.
CONCLUSIONS
In summary, we have successfully fabricated ultrasmall
stomatocyte polymersomes with uniform size (150 nm) by
applying the PEG addition method, and we have demonstrated
that this method can be systematically used for the shape
transformation of polymersomes under diﬀerent conditions.
Biocompatible catalyst catalase was encapsulated inside these
ultrasmall stomatocyte nanomotors in several seconds. By
decomposing H2O2, O2 was produced to power the motion of
USSNs even with a very low concentration of fuel.
Furthermore, the moving velocity of USSNs was found to
have a positive correlation with O2 production, which is also
concentration-dependent at the same time. The capability of
encapsulating enzymes in the inner compartment makes the
USSN a promising nanovesicle for biomedical applications,
such as protein delivery and imaging. Compared to small
stomatocyte nanomotors, USSNs were more eﬃcient in
penetrating a conﬂuent monolayer of pulmonary artery
endothelial cells, which suggests that more cargoes can be
delivered by USSNs than SSNs through the EPR eﬀect.
Moreover, USSNs were much more capable of internalizing
into the HeLa cells with or without the presence of H2O2 due
to the smaller size range and faster motion.
MATERIALS AND METHODS
All reagents and chemicals were purchased from commercial sources
and used as received. Milli-Q water (18.2 MΩ) was used in all of the
experiments. Catalase (E3289) from bovine liver, ≥20000 units/mg
protein, lyophilized powder, was purchased from Sigma-Aldrich.
Dynamic light scattering experiments were studied on a Malvern
Zetasizer Nano S equipped with a He−Ne (633 nm, 4 mW) laser and
an Avalanche photodiode detector at an angle of 173°. Transmission
electron microscopy samples were prepared in the following way: a
solution of sample (5 μL) was air-dried on a carbon-coated Cu TEM
grid (200 mesh). A JEOL TEM 1400 microscope at an acceleration
voltage of 120 kV and a JEOL TEM 2100 at an acceleration voltage of
200 kV were used for the characterization of shape transformation.
Synthesis of Poly(ethylene glycol)44-b-Poly(styrene)n. Poly-
merization of PEG-b-PS was reported in previous research.30
Molecular weights of the block copolymers were measured on a
Shimadzu Prominence GPC system equipped with a PL gel 5 μm
mixed D column (Polymer Laboratories) and diﬀerential refractive
index and UV (254 nm) detectors. NMR spectra were obtained on a
Varian Inova 400 spectrometer in CDCl3.
Preparation of Polymersomes. Modiﬁed from our previous
research,36 PEG44-b-PSn (10 mg) was dissolved in 1 mL of an organic
solvent mixture of tetrahydrofuran (THF) and 1,4-dioxane in a 4:1
ratio by volume with a magnetic stirring bar. After the solution was
dissolved for 30 min, 0.5 mL of Milli-Q water was added to the
solution at a rate of 1 mL h−1 at room temperature with vigorous
stirring (900 rpm) to make polymersomes. Ultrasmall polymersomes
were fabricated by passing 700 μL of polymersome solution through a
220 nm syringe ﬁlter (screening devices) in a mixture solvent of
THF/dioxane/water = 8/2/5 by volume.
Preparation of Ultrasmall Stomatocytes and Encapsulation
of Enzymes Inside the Stomatocyte Cavity via the PEG
Addition Method. The procedures for preparation of polymersomes
were the same as those described above. After polymersomes were
made, 30 μL of PEG2000 aqueous solution (100 mg/mL) was added
into the ultrasmall polymersome suspension (550 μL) under a stirring
speed of 900 rpm for 1 min. Ten milliliters of Milli-Q water was
poured into the solution to quench the structure. For encapsulating
enzymes inside stomatocytes, 1 mg of catalase was dissolved in 50 μL
of water and was added into the polymersome solution or ultrasmall
polymersome solution. After being mixed for 2 min with a stirring
plate, an appropriate amount of PEG2000 solution (100 mg/mL) was
added and the solutions were quenched as described. The organic
solvent and non-encapsulated enzymes in the system were removed
by centrifugation.
Solvent Addition Method for Reshaping Stomatocytes.
First, 500 μL of a rigid USSN solution was transferred into a 5 mL
vial. A THF/dioxane (4:1 v/v) mixture was added via a syringe pump
with the rate of 300 μL h−1 under a stirring speed of 900 rpm by using
a stirring plate. Samples were withdrawn and quenched at diﬀerent
time points (30, 60, 90, and 180 min). TEM and cryo-TEM sample
were made to follow the shape transformation.
Release of Enzymes from the Stomatocyte Cavity.
Encapsulated catalase was released from the stomatocyte by the
solvent addition method: 450 μL of THF/dioxane (4:1 v/v) was
added to 500 μL of rigid USSN solution as described above to
reshape the stomatocytes. Five milliliters of Milli-Q water was added
to quench the structure and dilute the organic solvent. Spin ﬁlters
with a 10 kDa membrane was used to remove the organic solvent and
collect the released enzymes. The presence of free enzymes was
checked by SDS-PAGE.
SDS-PAGE Analysis. SDS-PAGE was performed on a mini-
vertical electrophoresis system (Bio-Rad Mini-PROTEAN 2 Cell, Bio-
Rad Laboratories). Dilutions of catalase ranging from 5 μg to 125 ng
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were run on 10% Tris-glycine precast gels at 120 V for 60 min. An
electrode buﬀer (0.1% SDS, 0.25 M glycine, 0.025 M Tris-HCl, pH
8.3) was used as described in the manufacturer’s instructions. The gels
were stained by Coomassie Brilliant Blue R-250 staining solution and
washed by destaining solution for several times.
Autonomous Movement of the Stomatocyte Nanomotors.
The movement of nanomotors was evaluated at ﬁve diﬀerent H2O2
concentrations (0, 2, 5, 10, and 20 mM). Nanomotors (ﬁnal
concentration around 3 × 108 particles mL−1) were quickly injected
into the NanoSight LM10 sample chamber after being mixed with
H2O2 solution. Videos (each video duration time 30 s, rate 30 frames
s−1) were recorded, and the particle movement was analyzed with
nanoparticle tracking software (NTA 2.2).
Cell Uptake of Stomatocyte Nanomotors. Two hundred
microliters of Dulbecco’s modiﬁed Eagle’s medium (DMEM) buﬀer
with 1 × 105 cells was added to an 8-well plate (ibidi GmbH) and
incubated overnight at 37 °C. The incubation buﬀer was then
replaced by 200 μL of DMEM buﬀer with stomatocyte nanomotors
(particle concentration = 2 × 1010 particles/mL). After 3.5 h
incubation with or without 2 mmol H2O2, the cell culture medium
was removed, and cells were washed with PBS three times and ﬁxed
with 4% paraformaldehyde in PBS for 10 min at room temperature.
For nuclear staining, 4′,6-diamidino-2-phenylindole (DAPI) (Milli-
pore) was added and incubated for 1 h. After the staining solution was
removed, cells were washed with PBS buﬀer three times. The stained
cells were imaged by SP8× confocal microscope, and the presence of
ﬂuorescence was measured by Fiji.
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